When blood sugar levels drop quickly, stress to retinal blood vessels can occur, leading to bleeding, swelling, or scarring
On July 10, 2024, Kuei-Pin Huang and colleagues published a paper in Nature titled Dissociable Hindbrain GLP1R Circuits for Satiety and Aversion. The study suggests that future weight loss medications could selectively target GLP1R neurons in the nucleus of the solitary tract (NTS) to avoid inducing aversion, thereby improving treatment adherence and effectiveness [1]
Consequently, regular screening is advisable and there is much we can do with our Functional Toolkit
Medicaid spending on GLP-1s has grown exponentially over the past five years, reflecting both an increase in GLP-1 usage and expanded coverage in many states
These criteria are narrower than the general obesity indication that many commercial plans previously covered